Why Feasibility Should
Lead Antibody
Discovery
By Darcy Birse, PhD – General Manager, Antibody Solutions
Custom antibody development has become the cornerstone of modern biotechnology enabling researchers and diagnostic developers to generate highly specific antibodies tailored to their specific needs. While the science behind antibody generation is well established, challenges often arise from operational disconnects between early feasibility, validation and manufacturability. The central question is no longer whether science can deliver targeted, specific antibodies, but whether custom antibody development can generate reproducible evidence that supports reliable production and scaling.
Why Feasibility Matters
Feasibility in custom antibody development is more than a checkpoint; it is the foundation for reproducible, application-ready results. When feasibility is addressed early, you can gain insight into how custom antibody candidates behave across different assay formats, biological systems, and platforms.
Identifying and addressing risks during feasibility, reduces early rework, saves development time, and cost, and builds confidence that the custom antibody candidates will meet project requirements before scale-up or integration into test systems. This proactive approach helps teams make informed decisions about which candidates to advance, minimizing delays and maximizing the likelihood of success.
To further ensure antibody specificity, reproducibility, and reliability, our development process incorporates industry-recognized validation frameworks such as the Six Pillars of antibody validation. This structured approach strengthens confidence that antibodies will perform consistently in their intended applications.
Reproducibility as a Development Advantage
Reproducibility drives confidence in every custom antibody program. Consistent performance across assay formats and biological systems, allows teams to make informed choices about which candidates to advance. Structured validation covering specificity, sensitivity and biological relevance helps ensure each antibody behaves predictably across downstream assays.
By confirming specificity, consistency, and biological relevance early in the process, teams can strengthen reproducibility before optimization begins. This ensures that the antibodies generated are not only potent but also reliable for long-term use in research or diagnostic applications.
From Feasibility to Reliable Production
Manufacturability challenges often surface too late, after significant time, budget and resources have already been invested. Challenges like low expression, instability, or cross-reactivity often emerge late in poorly structured development workflows. Evaluating these factors early in the process during feasibility helps identify robust candidates. Assessing these attributes upfront reduces the likelihood of late-stage failure. This proactive approach ensures that the antibodies are practical to produce for long term use, reducing the likelihood of downstream failures.
A Framework for Confidence
A structured feasibility process strengthens reproducibility and performance, creating a direct link between early data and downstream success. By integrating feasibility assessments with validation planning, custom antibody development teams can minimize risks and confirm that generated antibodies will function as intended. This enables customers to access end-to-end support, from immunogen design and antibody generation to feasibility testing and application validation, building a stronger foundation for reproducible, assay-ready antibodies.
Operational Perspective
By focusing on early feasibility, reproducibility, and application fit, custom antibody development teams can deliver high-quality reagents that drive innovation and advance scientific discovery in biotechnology and diagnostics. This enables customers to access comprehensive support, ensuring that custom antibodies are tailored to their specific needs and validated for reliable performance.
